July 30, 2021 - ROSEN LOGO.jpg
ADSK ANNOUNCEMENT: If You Have Suffered Losses in Autodesk, Inc. (NASDAQ: ADSK), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 16, 2024 11:57 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Autodesk, Inc. (NASDAQ: ADSK) between June 1, 2023 and April...
July 30, 2021 - ROSEN LOGO.jpg
ALT ANNOUNCEMENT: If You Have Suffered Losses in Altimmune, Inc. (NASDAQ: ALT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 16, 2024 11:45 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April...
July 30, 2021 - ROSEN LOGO.jpg
AKRO ANNOUNCEMENT: If You Have Suffered Losses in Akero Therapeutics, Inc. (NASDAQ: AKRO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 16, 2024 11:18 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September 13,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LONGSTANDING LAW FIRM, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GL
June 16, 2024 10:36 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL)...
YOOZOO logo.PNG
6 New Games Unveiled and AI Playmate Launched: YOOZOO GAMES 616 "Youth Day" to Continue Global Expansion
June 16, 2024 10:00 ET | YOOZOO
Shanghai, China, June 16, 2024 (GLOBE NEWSWIRE) -- On June 16th, 2024, YOOZOO GAMES would celebrate its 15th anniversary with the 8th annual "616 Youth Day" under the theme "The Wonder of...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sprout Social, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPT
June 16, 2024 08:40 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprout Social, Inc. (NASDAQ: SPT) between November 2, 2023...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Malibu Boats, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– MBUU
June 16, 2024 07:47 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Malibu Boats, Inc. (NASDAQ: MBUU) between November 4, 2022...
July 30, 2021 - ROSEN LOGO.jpg
רוזן, יועץ למשקיעים מהימן, מעודד את משקיעי Marinus Pharmaceuticals, Inc. לקבל ייעוץ לפני תאריך יעד חשוב בתביעה ייצוגית בניירות ערך שהוגשה לראשונה על ידי החברה - MRNS
June 16, 2024 07:28 ET | The Rosen Law Firm PA
ניו יורק, June 16, 2024 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Marinus Pharmaceuticals, Inc....
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS
June 16, 2024 07:28 ET | The Rosen Law Firm PA
NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) between...
Regeneron Logo.jpg
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
June 16, 2024 06:10 ET | Regeneron Pharmaceuticals, Inc.
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71% overall response rate, as presented in an EHA oral presentation and simultaneously...